Catheter Precision, Inc. (VTAK)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 700K 1.4M 2.1M Q3 '21: 1.2M Q4 '21: 23K Q1 '22: 28K Q2 '22: 24K Q3 '22: 19K Q4 '22: 14K Q1 '23: 90K Q2 '23: 181K Q3 '23: 314K Q4 '23: 442K Q1 '24: 439K Q2 '24: 436K Q3 '24: 399K Q4 '24: 420K Q1 '25: 481K Q2 '25: 600K Q3 '25: 730K Q4 '25: 819K Q1 '26: 1.1M Q2 '26: 1.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '21: -1.6M Q4 '21: -1.5M Q1 '22: -1.2M Q2 '22: -730K Q3 '22: -489K Q4 '22: -147K Q1 '23: 14K Q2 '23: 164K Q3 '23: 291K Q4 '23: 412K Q1 '24: 414K Q2 '24: 402K Q3 '24: 361K Q4 '24: 378K Q1 '25: 433K Q2 '25: 554K Q3 '25: 676K Q4 '25: 756K Q1 '26: 1M Q2 '26: 914K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -31.2M Q4 '21: -29.3M Q1 '22: -27.9M Q2 '22: -29.6M Q3 '22: -27M Q4 '22: -27M Q1 '23: -87.9M Q2 '23: -85.8M Q3 '23: -83.7M Q4 '23: -78.1M Q1 '24: -14.3M Q2 '24: -10.7M Q3 '24: -10.8M Q4 '24: -11.2M Q1 '25: -12.2M Q2 '25: -14.2M Q3 '25: -14.3M Q4 '25: -21.1M Q1 '26: -19.9M Q2 '26: -19.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-90M -60M -30M 0 30M 60M 90M Q3 '21: -27.2M Q4 '21: -25.1M Q1 '22: -23.3M Q2 '22: -26.5M Q3 '22: -27M Q4 '22: -26.9M Q1 '23: -87.8M Q2 '23: -80.9M Q3 '23: -78.1M Q4 '23: -70.6M Q1 '24: -6.8M Q2 '24: -9.5M Q3 '24: -11.7M Q4 '24: -16.6M Q1 '25: -18M Q2 '25: -18.9M Q3 '25: -17M Q4 '25: -17.2M Q1 '26: -14.8M Q2 '26: -13M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 900K 1.8M 2.7M Q3 '21: 2.5M Q4 '21: 1.6M Q1 '22: 1.2M Q2 '22: 754K Q3 '22: 508K Q4 '22: 161K Q1 '23: 76K Q2 '23: 17K Q3 '23: 23K Q4 '23: 30K Q1 '24: 25K Q2 '24: 34K Q3 '24: 38K Q4 '24: 42K Q1 '25: 48K Q2 '25: 46K Q3 '25: 54K Q4 '25: 63K Q1 '26: 94K Q2 '26: 1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '21: -31.3M Q4 '21: -27.6M Q1 '22: -28.1M Q2 '22: -27.5M Q3 '22: -25.3M Q4 '22: -22.6M Q1 '23: -26.1M Q2 '23: -24.9M Q3 '23: -21.8M Q4 '23: -20.6M Q1 '24: -10.5M Q2 '24: -7.4M Q3 '24: -8.3M Q4 '24: -9.3M Q1 '25: -9.7M Q2 '25: -10.2M Q3 '25: -9.6M Q4 '25: -8.3M Q1 '26: -8.8M Q2 '26: -9.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-30M -20M -10M 0 10M 20M 30M Q3 '20: -28.6M Q4 '21: -27.9M Q1 '22: -28.4M Q2 '22: -27.7M Q3 '22: -25.3M Q4 '22: -22.6M Q1 '23: -26.1M Q2 '23: -25M Q3 '23: -21.8M Q4 '23: -20.7M Q1 '24: -10.6M Q2 '24: -7.4M Q3 '24: -8.4M Q4 '24: -9.3M Q1 '25: -9.7M Q2 '25: -10.2M Q3 '25: -9.7M Q4 '25: -8.3M Q1 '26: -8.8M Q2 '26: -9.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 1M 2M 3M Q2 '21: 4.1K Q3 '21: 128 Q2 '22: 32.2K Q3 '22: 1.1K Q1 '24: 742.9K Q2 '24: 757.3K Q3 '24: 108K Q1 '25: 593.9K Q2 '25: 701.9K Q3 '25: 1.3M Q1 '26: 2.2M Q2 '26: 2.8M Q3 '21 Q3 '22 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-150.00 -100.00 -50.00 0.00 50.00 100.00 150.00 Q2 '18: -1.99 Q3 '18: -2.35 Q4 '18: -3.33 Q1 '19: -4.15 Q2 '19: -4.28 Q3 '19: -4.99 Q4 '19: -108.27 Q1 '20: -121.09 Q2 '20: -130.64 Q3 '20: -132.60 Q4 '20: -21.22 Q1 '21: -9.72 Q4 '25: -18.67 Q1 '26: -13.25 Q2 '26: -6.89 Q2 '18 Q4 '18 Q2 '19 Q4 '19 Q2 '20 Q4 '20 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.